AAREYDRUGS
Invest Now
Start SIP in
AAREYDRUGS
Performance
- Low
- ₹53
- High
- ₹58
- 52 Week Low
- ₹31
- 52 Week High
- ₹75
- Open Price₹58
- Previous Close₹56
- Volume101,711
Investment Returns
- Over 1 Month -4.98%
- Over 3 Month + 25.43%
- Over 6 Month -2.31%
- Over 1 Year + 4.45%
Smart Investing Starts Here Start SIP with Aarey Drugs & Pharmaceuticals for Steady Growth!
Aarey Drugs & Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 26.5
- PEG Ratio
- 0.3
- Market Cap Cr
- 151
- P/B Ratio
- 1.1
- Average True Range
- 3.22
- EPS
- 2.01
- Dividend Yield
- 0
- MACD Signal
- 2
- RSI
- 53.12
- MFI
- 55.28
Aarey Drugs & Pharmaceuticals Financials
Aarey Drugs & Pharmaceuticals Technicals
EMA & SMA
Current Price
₹53.27
-2.57
(-4.6%)

-
- Bearish Moving Average 9
-
- Bullish Moving Average 7
- 20 Day
- ₹53.34
- 50 Day
- ₹50.30
- 100 Day
- ₹50.08
- 200 Day
- ₹51.19
Resistance and Support
54.71
- R3 61.14
- R2 59.48
- R1 56.37
- S1 51.60
- S2 49.94
- S3 46.83
Aarey Drugs & Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends
Date | Purpose | Remarks |
---|---|---|
2025-02-14 | Quarterly Results | |
2024-12-04 | To consider Fund Raising | |
2024-11-29 | Preferential issue of shares | Inter alia: a) To consider a proposal for issuance of equity shares by way of a preferential allotment. |
2024-11-14 | Quarterly Results | |
2024-10-01 | Others |
Aarey Drugs & Pharmaceuticals F&O
About Aarey Drugs & Pharmaceuticals
- NSE Symbol
- AAREYDRUGS
- BSE Symbol
- 524412
- Chairman & Managing Director
- Mr. Mihir R Ghatalia
- ISIN
- INE198H01019
Similar Stocks to Aarey Drugs & Pharmaceuticals
Aarey Drugs & Pharmaceuticals FAQs
Aarey Drugs & Pharmaceuticals share price is ₹53 As on 21 May, 2025 | 19:49
The Market Cap of Aarey Drugs & Pharmaceuticals is ₹151 Cr As on 21 May, 2025 | 19:49
The P/E ratio of Aarey Drugs & Pharmaceuticals is 26.5 As on 21 May, 2025 | 19:49
The PB ratio of Aarey Drugs & Pharmaceuticals is 1.1 As on 21 May, 2025 | 19:49
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.